Get our Free Patent Expiration Newsletter

Serving hundreds of leading biopharmaceutical companies globally:

Fish and Richardson
Accenture
Covington
Merck
AstraZeneca
Baxter

Generated: August 23, 2019

DrugPatentWatch Database Preview

Details for Biologics License Application: 125249

  Try a free trial


See Plans and Pricing

« Back to Dashboard

Summary for BLA: 125249
Tradename:ARCALYST
Applicant:Regeneron Pharmaceuticals
Ingredient:rilonacept
Patents:21
Approval Date:Feb 27, 2008
Suppliers: see list1

US Patents for BLA: 125249

Applicant Tradename Biologic Ingredient Dosage Form BLA Number Approval Date Patent No. Assignee Estimated Patent Expiration Status Orphan Source
Regeneron Pharmaceuticals ARCALYST rilonacept VIAL; SINGLE-USE 125249 001 2008-02-27   Try a Free Trial The Children\'s Hospital of Philadelphia (Philadelphia, PA) The Trustees of the University of Pennsylvania (Philadelphia, PA) 2034-04-21 RX Orphan search
Regeneron Pharmaceuticals ARCALYST rilonacept VIAL; SINGLE-USE 125249 001 2008-02-27   Try a Free Trial Occlugel (Jouy en Josas, FR) Centre National de la Recherche Scientifique (CNRS) (Paris, FR) Assistance Publique Hopitaux de Paris (Paris, FR) Universite Paris Diderot--Paris 7 (Paris, FR) 2031-03-09 RX Orphan search
Regeneron Pharmaceuticals ARCALYST rilonacept VIAL; SINGLE-USE 125249 001 2008-02-27   Try a Free Trial Laureate Institute For Brain Research (Tulsa, OK) 2034-12-04 RX Orphan search
Regeneron Pharmaceuticals ARCALYST rilonacept VIAL; SINGLE-USE 125249 001 2008-02-27   Try a Free Trial CardioForecast Ltd. (London, GB) 2037-01-12 RX Orphan search
Regeneron Pharmaceuticals ARCALYST rilonacept VIAL; SINGLE-USE 125249 001 2008-02-27   Try a Free Trial Regeneron Pharmaceuticals, Inc. (Tarrytown, NY) 2013-10-20 RX Orphan company
>Applicant >Tradename >Biologic Ingredient >Dosage Form >BLA >Number >Approval Date >Patent No. >Assignee >Estimated Patent Expiration >Status >Orphan >Source

Subscribe to access the full database, or try a Free Trial

Make Better Decisions: Try a trial or see plans & pricing

Serving hundreds of leading biopharmaceutical companies globally:

Argus Health
QuintilesIMS
Merck
Accenture
US Department of Justice
Moodys

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.